1. Home
  2. TIL vs HCAI Comparison

TIL vs HCAI Comparison

Compare TIL & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • HCAI
  • Stock Information
  • Founded
  • TIL 2018
  • HCAI 2004
  • Country
  • TIL United States
  • HCAI China
  • Employees
  • TIL N/A
  • HCAI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • HCAI Miscellaneous manufacturing industries
  • Sector
  • TIL Health Care
  • HCAI Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • HCAI Nasdaq
  • Market Cap
  • TIL 171.7M
  • HCAI 161.3M
  • IPO Year
  • TIL 2021
  • HCAI 2025
  • Fundamental
  • Price
  • TIL $22.12
  • HCAI $3.95
  • Analyst Decision
  • TIL Strong Buy
  • HCAI
  • Analyst Count
  • TIL 4
  • HCAI 0
  • Target Price
  • TIL $114.00
  • HCAI N/A
  • AVG Volume (30 Days)
  • TIL 83.9K
  • HCAI 526.0K
  • Earning Date
  • TIL 03-20-2025
  • HCAI 01-01-0001
  • Dividend Yield
  • TIL N/A
  • HCAI N/A
  • EPS Growth
  • TIL N/A
  • HCAI N/A
  • EPS
  • TIL N/A
  • HCAI 0.11
  • Revenue
  • TIL N/A
  • HCAI $53,677,586.00
  • Revenue This Year
  • TIL N/A
  • HCAI N/A
  • Revenue Next Year
  • TIL N/A
  • HCAI N/A
  • P/E Ratio
  • TIL N/A
  • HCAI $37.24
  • Revenue Growth
  • TIL N/A
  • HCAI 534.84
  • 52 Week Low
  • TIL $9.62
  • HCAI $3.70
  • 52 Week High
  • TIL $92.00
  • HCAI $5.32
  • Technical
  • Relative Strength Index (RSI)
  • TIL 48.67
  • HCAI N/A
  • Support Level
  • TIL $19.00
  • HCAI N/A
  • Resistance Level
  • TIL $25.80
  • HCAI N/A
  • Average True Range (ATR)
  • TIL 2.19
  • HCAI 0.00
  • MACD
  • TIL 0.22
  • HCAI 0.00
  • Stochastic Oscillator
  • TIL 45.88
  • HCAI 0.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider.

Share on Social Networks: